Man with a chronic illness completes Edinburgh Marathon while vlogging his experience
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info
A man with a chronic illness completed the Edinburgh Marathon while vlogging about the challenges of undertaking the massive challenge.
Callum, an influencer with type one diabetes, posts videos online about living with the illness.
He was diagnosed with type one diabetes when he began drastically losing weight and his eyesight "fell off a cliff" and he suddenly could not "read the number plate in front of him".
The influencer shared his story on TikTok, saying "But here I am today - the fittest I've ever been, probably the healthiest I've ever been aside from having type one diabetes."
Type one diabetes is a condition where the body cannot produce insulin, the hormone which breaks down sugar to use as energy. As a result, blood sugar levels become too high in the blood and lead to complications, according to the NHS.
On Sunday, May 25, he completed the 26-mile Edinburgh Marathon and shared a vlog about completing the enormous physical effort while sharing his blood sugar levels every five kilometers.
Throughout his impressive four-hour marathon race, his blood sugar ranged from low to high, showcasing the daily ups-and-downs that come with living with type one diabetes.
For healthy individuals, normal fasting blood sugar levels are between 4.0 to 5.4 mmol/L, and up to 7.8 mmol/L two hours after eating, according to Diabetes UK.
Callum's ranged from 11.1 mmol/L to much lower. When Callum was 33km into the race, he shared an update when his blood sugar was at 4.5 mmol/L, saying: "Thirty-three kilometers in, blood sugar still dropping, so I'm just going to wlak for a bit to see if I can level this out because I've had so much sugar. Still not going up."
Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages.
He completed the race with a time of around four hours, saying "That was tough" upon crossing the finish line.
The video garnered over 46,000 views less than 24 hours.
Callum has previously posted on social media saying "Doing any type of long distance running when you have type one diabetes can be pretty annoying due to the amount of extra stuff you have to bring. The main things to bring with you are a ton of emergency sugar and to make sure you're carrying your insulin pen with you."
On his post from the Edinburgh Marathon on Sunday, he posted with the caption: "Edinburgh Marathon 2025 with my blood sugar levels throughout.
"I met a lot of other people with type one diabetes as well as a lot of people raising money for it which is always amazing to see.
"It really was a four season kind of day from beautiful sunshine to really heavy winds to rain and hailstones at one point which were absolutely awful. Still good, still happy. I ran a marathon with type one diabetes."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
16 minutes ago
- South Wales Argus
Newport will be home of NHS radioactive injectables facility
The radiopharmacy will manufacture life-saving treatments for use across South East Wales from the former Essentra packing plant on Imperial Park industrial estate in the city. The medicines produced at the site, primarily used in diagnostic scans, are essential for identifying serious conditions such as cancer. Jeremy Miles, cabinet secretary for health and social care, said: "It's been great to see the progress to build a new radiopharmacy facility at Imperial Park. "Radiopharmaceuticals are highly-specialised medicines essential for many procedures and treatments used by the NHS. "I'm delighted the Welsh Government is providing the funding to make this happen. "This new facility will benefit people across South East Wales and ensure the NHS has access to the specialist medicines it needs. "Radiopharmacy is part of the plans to increase NHS Wales' capacity to produce specialist anti-cancer therapies, intravenous nutrition and other sterile medicines. "The Imperial Park site will be central to transforming the availability of these medicines in Wales." Funded through the Welsh Government's capital programme, the £7.6 million development forms part of the wider £67 million Transforming Access to Medicines (TrAMs) plan, which aims to modernise pharmacy technical services across Welsh hospitals. The radiopharmacy will support growing demand for diagnostic scans that rely on radioactive injectables, some of which have a shelf life of only a few hours due to radioactive decay. By improving the supply chain and production capacity, the facility will help ensure that these time-sensitive medicines reach patients promptly. Neil Frow, managing director of NHS Wales Shared Services Partnership which will run the project, said: "We are pleased to host the cabinet secretary in Newport today to see the difference this radiopharmacy facility will make to patients across South East Wales first hand. "Thanks to Welsh Government funding, NHS Wales Shared Services Partnership can ensure we have the capacity to make and deliver vital high quality medicines to hospitals across this part of Wales, which will improve patient care and drive down waiting times. "This facility is a key milestone and we are proud to be at the forefront of making sure pharmacy technical services across NHS Wales are fit for the future." Construction began in June and the facility is expected to be operational by spring 2026. The site will not serve patients directly but will supply health boards with the injectables needed for diagnostic and therapeutic procedures in hospitals.
South Wales Argus
16 minutes ago
- South Wales Argus
AI foot scanner could keep people with heart failure out of hospital
The device, which is roughly the size of a smart speaker, operates in a similar way to facial recognition by taking and analysing almost 2,000 pictures a minute to calculate the level of fluid in the feet and ankles. This water retention, known as oedema, is one of the three major warning signs that heart failure is becoming severe and potentially life threatening. The AI scanner is able to trigger an alert to healthcare professionals so they can take action, such as increasing their patient's medication. The Foot Study, which is being presented at the British Cardiovascular Society annual conference in Manchester, suggests these alerts come 13 days before a person would end up in hospital. It involved 26 heart failure patients from five NHS trusts who were enrolled between 2020 and 2022. They were monitored using the AI device and were also asked to weigh themselves using Bluetooth-enabled scales. Seven instance of worsening heart failure was detected in six patients, while one death from the condition was recorded. Researchers found that, in patients enrolled in the study for at least two weeks before an alert was triggered, the average lead time before hospital admission was 13 days. The lead time averaged eight days when all five triggers picked up by the device were analysed. The study also found that monitoring using the scales failed to predict any heart failure-related hospital admissions. Researchers suggested this is because patients struggled to stick to tracking their weight, whereas the AI device did not require any action. Dr Philip Keeling, senior author of the study and a consultant cardiologist at Torbay and South Devon NHS Foundation Trust, said: 'Only about half of people admitted to hospital with heart failure currently get assigned an early review by a heart failure nurse who can check to see if they are suffering a harmful build-up of fluid because their heart is not working properly. 'Amid a shortage of heart failure nurses, a device like this can be like a virtual nurse, tracking people's health.' The device, developed by Cambridge-based start-up Heartfelt Technologies, is mounted to the wall and is typically installed at a patient's bedside. It uses AI technology to detect a person's foot and lower leg and track their position, so a camera can take 1,800 pictures a minute from multiple angles. These images reveal the volume of fluid in the foot and lower leg. It works without wifi, and only scans the legs to a height of 50cm from the floor. Heart failure is a long-term condition that means the heart is unable to pump blood around the body properly, usually because the heart has become too weak or stiff. Is it estimated that more than a million people are living with heart failure in the UK. The three main symptoms that indicate the condition is getting worse are increased breathlessness, weight gain and swelling in the legs or ankles. Dr Keeling added: 'Living with heart failure can be overwhelming, with all the medications, medical tests and appointments, and the requirement to monitor your own health. 'This scanner, once it is installed, just automatically keeps an eye on you and alerts the heart failure nurse, which is a huge relief.' At the end of the study, 18 of the 22 surviving patients kept the AI device. Reacting to the findings, Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation (BHF), said: 'This small study suggests a simple device could significantly improve outcomes for at-risk patients with heart failure by keeping them out of hospital. 'This study is a good example of how technology might aid earlier interventions and treatment, by allowing people to track a key sign of their heart health at home. 'Innovations with the potential to transform heart care in this way are a major part of the BHF's goal to save and improve lives of people living with cardiovascular disease.'
The Herald Scotland
an hour ago
- The Herald Scotland
AI foot scanner could keep people with heart failure out of hospital
This water retention, known as oedema, is one of the three major warning signs that heart failure is becoming severe and potentially life threatening. The AI scanner is able to trigger an alert to healthcare professionals so they can take action, such as increasing their patient's medication. The Foot Study, which is being presented at the British Cardiovascular Society annual conference in Manchester, suggests these alerts come 13 days before a person would end up in hospital. It involved 26 heart failure patients from five NHS trusts who were enrolled between 2020 and 2022. They were monitored using the AI device and were also asked to weigh themselves using Bluetooth-enabled scales. Seven instance of worsening heart failure was detected in six patients, while one death from the condition was recorded. Researchers found that, in patients enrolled in the study for at least two weeks before an alert was triggered, the average lead time before hospital admission was 13 days. The lead time averaged eight days when all five triggers picked up by the device were analysed. The study also found that monitoring using the scales failed to predict any heart failure-related hospital admissions. Researchers suggested this is because patients struggled to stick to tracking their weight, whereas the AI device did not require any action. Dr Philip Keeling, senior author of the study and a consultant cardiologist at Torbay and South Devon NHS Foundation Trust, said: 'Only about half of people admitted to hospital with heart failure currently get assigned an early review by a heart failure nurse who can check to see if they are suffering a harmful build-up of fluid because their heart is not working properly. 'Amid a shortage of heart failure nurses, a device like this can be like a virtual nurse, tracking people's health.' The device, developed by Cambridge-based start-up Heartfelt Technologies, is mounted to the wall and is typically installed at a patient's bedside. It uses AI technology to detect a person's foot and lower leg and track their position, so a camera can take 1,800 pictures a minute from multiple angles. These images reveal the volume of fluid in the foot and lower leg. It works without wifi, and only scans the legs to a height of 50cm from the floor. Heart failure is a long-term condition that means the heart is unable to pump blood around the body properly, usually because the heart has become too weak or stiff. Is it estimated that more than a million people are living with heart failure in the UK. The three main symptoms that indicate the condition is getting worse are increased breathlessness, weight gain and swelling in the legs or ankles. Dr Keeling added: 'Living with heart failure can be overwhelming, with all the medications, medical tests and appointments, and the requirement to monitor your own health. 'This scanner, once it is installed, just automatically keeps an eye on you and alerts the heart failure nurse, which is a huge relief.' At the end of the study, 18 of the 22 surviving patients kept the AI device. Reacting to the findings, Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation (BHF), said: 'This small study suggests a simple device could significantly improve outcomes for at-risk patients with heart failure by keeping them out of hospital. 'This study is a good example of how technology might aid earlier interventions and treatment, by allowing people to track a key sign of their heart health at home. 'Innovations with the potential to transform heart care in this way are a major part of the BHF's goal to save and improve lives of people living with cardiovascular disease.'
